Emerging basic, preclinical, and clinical findings indicated that epidermal growth factor receptor (EGFR)-mediated aberrant signaling transduction is crucial in HNSCC tumorigenesis and progression [6]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.